FDA-AVTO, OOO, Smolensk Oblast

Economic indicators

Net profit (RAS) of FDA-AVTO, OOO made up 0 RUB over 2023 compared to net loss of 951.00 thousand RUB over 2022, the company informed.

Revenue decreased in the accounting period ? times to 0.00 thousand RUB from 4.17 million RUB in 2022; cost of goods sold decreased ? times to 0.00 thousand RUB from 3.60 million RUB; sales profit made up 0 RUB compared to 41.00 thousand RUB.

Net loss (RA) of FDA-AVTO, OOO made up 951.00 thousand RUB over 2022 compared to net profit of 511.00 thousand RUB over 2021, the company informed.

Revenue decreased in the accounting period by 35.89% to 4.17 million RUB from 6.51 million RUB in 2021; cost of goods sold decreased by 36.55% to 3.60 million RUB from 5.68 million RUB; sales profit fell 11.63 times to 41.00 thousand RUB from 477.00 thousand RUB.

Net profit (RAS) of FDA-AVTO, OOO made up 511.00 thousand RUB over 2021 compared to net loss of 1.55 million RUB over 2020, the company informed.

Revenue increased in the accounting period by 12.71% to 6.51 million RUB from 5.77 million RUB over 2020; cost of goods sold grew by 12.65% to 5.68 million RUB from 5.04 million RUB; sales profit made up 477.00 thousand RUB compared to sales loss of 1.28 million RUB.

Net loss (RA) of FDA-AVTO, OOO made up 1.55 million RUB over 2020 compared to net profit of 1.70 million RUB over 2019, the company informed.

Revenue increased in the accounting period 1.65 times to 5.77 million RUB from 3.50 million RUB over 2019; cost of goods sold grew 3.51 times to 5.04 million RUB from 1.44 million RUB; sales loss made up 1.28 million RUB compared to sales profit of 1.91 million RUB.

Net profit (RAS) of FDA-AVTO, OOO dropped in 2018 15.42 times to 52.00 thousand RUB from 802.00 thousand RUB over the same period in 2017, the company informed.

Revenue decreased in the accounting period 3.56 times to 606.00 thousand RUB from 2.16 million RUB in 2017; cost of goods sold decreased 3.50 times to 335.00 thousand RUB from 1.17 million RUB; sales profit fell 4.20 times to 235.00 thousand RUB from 986.00 thousand RUB.

Net profit (RAS) of FDA-AVTO, OOO grew over 2017 by 4.97% to 802.00 thousand RUB from 764.00 thousand RUB over 2016, the company informed.

Revenue increased in the accounting period by 5.01% to 2.16 million RUB from 2.06 million RUB over 2016; cost of goods sold grew by 5.01% to 1.17 million RUB from 1.12 million RUB; sales profit went up by 5.01% to 986.00 thousand RUB from 939.00 thousand RUB.

Companies in the region

• SPETSSTROY
• AVTOZAPAD
• PREM'ERA
• AVTOGLOBUS
• ARMAN